CC BY-NC-ND 4.0 · J Neurol Surg Rep 2023; 84(01): e6-e10
DOI: 10.1055/a-2008-4161
Case Report

Neurofibromatosis Type 1 with Giant Thrombotic Aneurysm of the Internal Carotid Artery Presenting with Rapid Progression of Visual Disturbance: A Case Report and Literature Review

1   Division of Neurosurgery, Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
,
Naoki Otani
1   Division of Neurosurgery, Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
,
Ryuta Kajimoto
1   Division of Neurosurgery, Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
,
Takamichi Katsuhara
1   Division of Neurosurgery, Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
,
Atsuo Yoshino
1   Division of Neurosurgery, Department of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan
› Author Affiliations

Abstract

Background Patients with neurofibromatosis type 1 (NF1) have various vascular diseases due to the vascular fragility, but no reports of case of giant thrombotic aneurysm was found. We treated a rare case of giant thrombotic aneurysm of the internal carotid artery (ICA) in a patient with NF1.

Case Presentation A 60-year-old man had suffered deteriorating visual loss and homonymous hemianopia. Contrast-enhanced computed tomography showed a giant thrombosed aneurysm on the anterior wall of the ICA located in the optic chiasma. We planned and completed the external carotid artery-middle cerebral artery high-flow bypass using radial artery graft. The visual fields test was performed 14 days after surgery. Homonymous hemianopia persisted but no exacerbation of visual field impairment was observed. No complications were found at 14 days after surgery and the postoperative course was uneventful.

Conclusion We consider that external carotid artery-middle cerebral artery bypass surgery using radial artery grafts is a safe and effective treatment method for giant thrombotic aneurysm associated with NF1.

Ethics Approval and Consent to Participate

None.


Consent for Publication

The patient has consented to submission of this case report for journal publication, and we have obtained written informed consent.


Availability of Data and Materials

None.


Authors' Contributions

M.K. contributed to the concept of the manuscript and drafted the manuscript. N.O. and A.Y. revised the manuscript and contributed to the concept of manuscript. R.K. and T.K. contributed to the obtainment and interpretation of the clinical information. All authors have read and approved the manuscript.




Publication History

Received: 19 April 2022

Accepted: 13 December 2022

Accepted Manuscript online:
05 January 2023

Article published online:
16 January 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany